ECOM cardiac output for Hemodynamic Monitoring

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hemodynamic MonitoringECOM cardiac output - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the accuracy of a new cardiac output monitor to two existing ones.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Muscle Fiber Fragments (MFFs)
1
Sucralfate
1
Autologous Muscle Fiber Fragments

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 months.

6 months.
Comparison of ECOM Plus impedance and thermal dilution cardiac output measurements

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Muscle Fiber Fragments (MFFs)
2
Sucralfate
1
Autologous Muscle Fiber Fragments

Trial Design

1 Treatment Group

Single Group Assignment
1 of 1

Experimental Treatment

110 Total Participants · 1 Treatment Group

Primary Treatment: ECOM cardiac output · No Placebo Group · N/A

Single Group Assignment
Device
Experimental Group · 1 Intervention: ECOM cardiac output · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months.

Who is running the clinical trial?

ECOM Medical, Inc.Lead Sponsor
Arthur Wallace, MDPrincipal InvestigatorVA San Francisco

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top